Author

Srija Chakraborty

The Ohio State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Aleksander SkardaliD· 2 shared Alexander E. DaviesiD· 1 shared Anna E. VilgelmiD· 1 shared Connor Durham· 1 shared Marco RodrigueziD· 1 shared Marina CapeceiD· 1 shared Vijaya BhartiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aleksander SkardalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evaluation of natural killer cell tumor homing and effector function in response to CDK4/6 and AURKA inhibition in a melanoma tumor-on-a-chip platform

Srija Chakraborty, Connor Durham, Vijaya Bharti, Marina Capece, Alexander E. Davies, Anna E. Vilgelm, Aleksander Skardal

This study evaluates how CDK4/6 and AURKA inhibition enhances NK cell homing and tumor-killing in melanoma models using tumor-on-a-chip platforms.

bioRxiv · Jul 9, 2025 · PreprintCancer Biology

Fibroblasts drive differential response in immunotherapy via IL-6 in bioengineered 3D cancer constructs

Srija Chakraborty, Marco Rodriguez, Aleksander Skardal

This study investigates how fibroblasts influence immunotherapy efficacy in 3D cancer models, identifying IL-6 as a key mediator of tumor-fibroblast interactions that can be targeted to restore NK cell function.

bioRxiv · Jun 18, 2025 · PreprintCancer Biology